Breaking News Instant updates and real-time market news.

ABM

ABM

$39.83

0.22 (0.56%)

, AEGN

Aegion

$15.20

0.11 (0.73%)

04:55
06/13/19
06/13
04:55
06/13/19
04:55

Maxim Group to hold a conference

Industrial Conference to be held in New York on June 12-13.

ABM

ABM

$39.83

0.22 (0.56%)

AEGN

Aegion

$15.20

0.11 (0.73%)

AMRC

Ameresco

$13.89

0.13 (0.94%)

CECE

CECO Environmental

$9.17

0.36 (4.09%)

EVSI

Envision Solar

$4.89

-0.015 (-0.31%)

FIX

Comfort Systems USA

$48.37

-0.11 (-0.23%)

GHM

Graham

$20.66

-0.31 (-1.48%)

ICFI

ICF International

$74.57

0.05 (0.07%)

MG

Mistras

$13.63

0.03 (0.22%)

MYRG

MYR Group

$33.15

-0.3 (-0.90%)

NVEE

NV5 Global

$76.51

-0.35 (-0.46%)

SGBX

SG Blocks

$0.80

-0.05 (-5.88%)

TTEK

Tetra Tech

$72.67

0.39 (0.54%)

  • 13

    Jun

  • 18

    Jun

  • 19

    Jun

  • 25

    Jun

  • 25

    Sep

  • 13

    Nov

ABM ABM
$39.83

0.22 (0.56%)

01/11/19
KING
01/11/19
DOWNGRADE
KING
Neutral
ABM downgraded to Neutral from Buy at CL King
CL King downgraded ABM to Neutral citing fair valuation, difficult comps, and continued labor pressures.
02/14/19
MAXM
02/14/19
INITIATION
Target $45
MAXM
Buy
ABM initiated with a Buy at Maxim
Maxim analyst Tate Sullivan initiated ABM with a Buy rating and a price target of $45, citing its "momentum in integrating energy efficiency projects into existing facility management contracts with large clients." The analyst further cites the company's growing number of energy efficiency projects announced in 2018-2019 and higher short interest after its 2017 acquisition of GCA Services.
04/05/19
KEYB
04/05/19
INITIATION
KEYB
Sector Weight
ABM initiated with a Sector Weight at KeyBanc
KeyBanc analyst Sean Eastman initiated ABM Industries with a Sector Weight rating, saying he views the company as a compelling, late-cycle/defensive play. He also views nascent strategic initiatives as having the potential to support structurally higher organic growth and margins long-term. He looksfor better visibility on margin trajectory toward management's target given the tight labor capacity, limited pricing upside/operating leverage in ABM's mature business lines, and restrictive leverage keeping ABM sidelined from strategic acquisitions.
02/14/19
02/14/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Catasys (CATS) initiated with an Outperform at Oppenheimer. 2. Harmonic (HLIT) initiated with a Buy at Needham. 3. Allegheny Technologies (ATI) initiated with an Outperform at Macquarie. 4. ABM (ABM) initiated with a Buy at Maxim. 5. CSG (CSGS) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
AEGN Aegion
$15.20

0.11 (0.73%)

01/08/19
MAXM
01/08/19
INITIATION
Target $18
MAXM
Hold
Aegion initiated with a Hold at Maxim
Maxim analyst Tate Sullivan initiated Aegion with a Hold rating and a price target of $18. The analyst cites the company facing risk of rising costs from its "current restructuring effort and ahead of potential progress selling more drinking water pipe products" but also believes that the downside can be limited by its "sustainable water infrastructure businesses and more share repurchases at the beginning of 2019".
11/01/18
11/01/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Pfizer (PFE) downgraded to Market Perform from Outperform at BMO Capital with analyst Alex Arfaei saying he maintains a positive view on the company longer-term but sees valuation at current levels reflecting its risk-reward profile. 2. Encana (ECA) downgraded to Underperformer from Neutral at CIBC. 3. New Oriental Education (EDU) downgraded to Hold from Buy at Deutsche Bank with analyst Tallan Zhou saying he expects "lingering margin pressure" following Q1 results. 4. Autoliv (ALV) downgraded to Neutral from Buy at Longbow with analyst Anthony Deem saying he sees the company's revenue growth being "very solid" through 2020 in mid-to-high single digit percentage territory, but he is less confident in positive operating leverage due to incremental cost overruns associated with new launches. 5. Aegion (AEGN) downgraded to Hold from Buy at Canaccord with analyst Chip Moore saying the company is a well positioned pipeline infrastructure play that is poised to benefit from attractive secular drivers longer-term, but the risk/reward is balanced at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/18
ADAM
11/01/18
DOWNGRADE
Target $23
ADAM
Hold
Aegion downgraded to Hold from Buy at Canaccord
Canaccord analyst Chip Moore downgraded Aegion to Hold from Buy after assuming coverage. He said the company is a well positioned pipeline infrastructure play that is poised to benefit from attractive secular drivers longer-term, but the risk/reward is balanced at current levels. Moore lowered the price target to $23 from $27 on Aegion shares.
01/07/19
MAXM
01/07/19
INITIATION
Target $18
MAXM
Hold
Aegion initiated with a Hold at Maxim
Price target $18.
AMRC Ameresco
$13.89

0.13 (0.94%)

03/07/19
ADAM
03/07/19
NO CHANGE
Target $20
ADAM
Buy
Ameresco price target raised to $19.50 from $16.50 at Canaccord
Canaccord analyst Chip Moore raised his price target on Ameresco to $19.50 from $16.50 following solid Q4 results. The analyst cited its fully contracted back log which provides good visibility, the continued acceleration of its asset portfolio, and what he sees as an attractive risk/reward. Moore reiterated his Buy rating on Ameresco shares.
03/13/19
RILY
03/13/19
INITIATION
Target $19
RILY
Buy
Ameresco resumed with a Buy at B. Riley FBR
B. Riley FBR analyst Christopher Van Horn resumed coverage of Ameresco with a Buy rating and $19 price target. The rating and price target are unchanged from the firm's prior coverage.
03/04/19
ROTH
03/04/19
UPGRADE
Target $19
ROTH
Buy
Ameresco upgraded to Buy from Neutral at Roth Capital
Roth Capital analyst Craig Irwin upgraded Ameresco to Buy from Neutral as he expects the company to report "strong" Q4 results, supported by rising ESPC project activity and continued strengthening of the EBITDA contribution from the Canton-GNG plant. Looking forward, the Phoenix-GNG plant should drive a $15M step up in 2019 EBITDA, in addition to the tail from the 2018 Canton ramp, pointing to good potential for execution well above consensus, he contends. Irwin also raised his price target on the shares to $19 from $16.
12/19/18
RILY
12/19/18
INITIATION
Target $17.5
RILY
Buy
Ameresco initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Carter Driscoll started Ameresco with a Buy rating and $17.50 price target. The company's recurring revenue and backlog make it a "defensive play on efficiency," Driscoll tells investors in a research note.
CECE CECO Environmental
$9.17

0.36 (4.09%)

06/11/19
ROTH
06/11/19
UPGRADE
ROTH
Buy
CECO Environmental upgraded to Buy from Neutral at Roth Capital
Roth Capital analyst Gerry Sweeney upgraded CECO Environmental to Buy from Neutral.
03/13/19
RILY
03/13/19
INITIATION
Target $9.5
RILY
Buy
CECO Environmental resumed with a Buy at B. Riley FBR
B. Riley FBR analyst Christopher Van Horn resumed coverage of CECO Environmental with a Buy rating and $9.50 price target. The rating and price target are unchanged from the firm's prior coverage.
06/11/19
ROTH
06/11/19
UPGRADE
Target $10
ROTH
Buy
CECO Environmental upgraded to Buy at Roth Capital
As previously reported, Roth Capital analyst Gerry Sweeney upgraded CECO Environmental to Buy from Neutral, citing improving revenue base, reduced complexity in operating structure, significant debt reduction and as he believes acquisitions will likely come back in to the picture. Overall, the analyst thinks management is creating a more sustainable industrial platform which leverages its improving sales efforts, emerging R&D and streamlined operations. He also raised his price target on the shares to the shares to $10 from $8.
02/12/19
02/12/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Viavi (VIAV) initiated with an Outperform at Northland. 2. CECO Environmental (CECE) initiated with a Buy at B. Riley FBR. 3. Tencent Music (TME) initiated with an Outperform at Macquarie. 4. Enable Midstream (ENBL) initiated with a Neutral at Mizuho. 5. Elanco (ELAN) initiated with a Market Perform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
EVSI Envision Solar
$4.89

-0.015 (-0.31%)

FIX Comfort Systems USA
$48.37

-0.11 (-0.23%)

01/02/19
SIDC
01/02/19
UPGRADE
SIDC
Buy
Comfort Systems USA upgraded to Buy from Neutral at Sidoti
03/12/19
SIDC
03/12/19
DOWNGRADE
SIDC
Neutral
Comfort Systems USA downgraded to Neutral from Buy at Sidoti
07/30/18
DADA
07/30/18
NO CHANGE
Target $55
DADA
Neutral
Comfort Systems USA price target raised to $55 from $48 at DA Davidson
DA Davidson analyst Brent Thielman raised his price target on Comfort Systems USA to $55 after its Q2 earnings beat, saying the quarter saw a "very strong quarter of 'same- store' sales and backlog growth". The analyst notes that the company is benefiting from an "active" non-residential market environment, cash flows, and impressive efficiency ratio. Thielman also kept his Neutral rating on Comfort Systems, warning about a potential moderation in growth rates beyond the "early cycle" for its products.
11/21/18
DADA
11/21/18
NO CHANGE
Target $8
DADA
Buy
Limbach Holding price target lowered to $8 from $15 at DA Davidson
DA Davidson analyst Brent Thielman lowered his price target on Limbach Holdings (LMB) to $8 after its Q3 earnings miss, saying the company has experienced "significant execution challenges in the Mid-Atlantic, culminating into three consecutive quarters of underwhelming profitability". In addition to these issues, the analyst also cites the industry valuation compression. Thielman keeps his Buy rating on Limbach Holdings, noting that "salvage value and recovery potential" exist for this "interesting concoction of growth and mix shift". The analyst further states that Limbach Holdings represents a smaller version of the "very successful" and cash flow-rich Comfort Systems (FIX) and EMCOR (EMKR).
GHM Graham
$20.66

-0.31 (-1.48%)

04/18/19
MAXM
04/18/19
INITIATION
MAXM
Buy
Graham initiated with a Buy at Maxim
04/18/19
MAXM
04/18/19
INITIATION
Target $27
MAXM
Buy
Graham initiated with a Buy at Maxim
Maxim analyst Tate Sullivan initiated Graham with a Buy rating and a price target of $27, citing the company's "record backlog from U.S. Navy" for aircraft carrier and submarine equipment which should lead to a "meaningful rebound" in earnings. The analyst also believes that Graham may announce a 10% dividend increase in August after its first divident increase in 3 years in 2018 while anticipating the company's "less cyclical than other end markets' " orders from the U.S. Navy to continue to grow.
04/18/19
04/18/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Yelp (YELP) initiated with an Outperform at BMO Capital. 2. Ruth's Hospitality (RUTH) initiated with an Equal Weight at Stephens. 3. Conmed (CNMD) initiated with a Buy at Stifel. 4. Alcon (ALC) initiated with a Market Perform at BMO Capital. 5. Graham (GHM) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ICFI ICF International
$74.57

0.05 (0.07%)

02/27/19
LOOP
02/27/19
NO CHANGE
Target $89
LOOP
Buy
ICF International guidance for FY19 'quite achievable', says Loop Capital
Loop Capital analyst Joseph Vafi kept his Buy rating and $89 price target on ICF International, saying the company's FY19 guidance was "very attractive" with "all of its business lines set up for growth and potential margin expansion". The analyst notes that the company's hurricane-related opportunities are converting and ramping up with more funds in the FEMA Puerto Rico and Texas HUD contracts, adding that several billion dollars in Community Development Block Grant related funds are also yet to be awarded. In light of its strong momentum exiting 2018, Vafi believes that ICF International outlook for FY19 is "quite achievable".
12/06/18
BRRR
12/06/18
NO CHANGE
Target $86
BRRR
Outperform
ICF International still has upside after year-to-date rise, says Barrington
After hosting investor meetings this week with the COO of ICF International, Barrington analyst Kevin Steinke said he came away with additional conviction in his recommendation of the stock. Even after a 31% increase in the stock since the beginning of 2018, Steinke sees further upside potential for the shares, he tells investors. The company estimates that approximately $25B of funds appropriated for disaster recovery will be allocated to housing recovery programs, and Steinke sees ICF as "well-positioned to win its fair share" of housing recovery work, the analyst added. He maintains an Outperform rating and $86 price target on ICF International shares.
09/28/18
LOOP
09/28/18
NO CHANGE
Target $89
LOOP
Buy
ICF International portfolio 'close to having stars aligned', says Loop Capital
Loop Capital analyst Joseph Vafi kept his Buy rating and $89 price target on ICF International, saying that his recent meetings with its management increased his confidence in the prospects of the company's consulting services portfolio. The analyst notes that he expects ICF to have a "material earnings ramp" over the next few quarters and for the "tempo of disaster relief-related opportunities" to accelerate. Outside disaster relieve, Vafi adds that he is "positive on some of ICF's core end markets, including energy efficiency, health, and digital marketing".
02/13/19
BREN
02/13/19
INITIATION
Target $77
BREN
Hold
ICF International initiated with a Hold at Berenberg
Berenberg analyst Sam England initiated ICF International with a Hold and $77 price target.
MG Mistras
$13.63

0.03 (0.22%)

06/22/18
SIDC
06/22/18
UPGRADE
SIDC
Buy
Mistras upgraded to Buy from Neutral at Sidoti
MYRG MYR Group
$33.15

-0.3 (-0.90%)

05/16/19
05/16/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Macy's (M) upgraded to Neutral from Sell at Goldman Sachs with analyst Alexandra Walvis saying she sees a more balanced risk/reward in the wake of the stock's recent underperformance. 2. SAIC (SAIC) upgraded to Outperform from Market Perform at Wells Fargo with analyst Edward Caso saying he has "growing comfort" with the company's ongoing integration of its Engility acquisition and sees the deal producing a "notable improvement" in free cash flow. 3. Scorpio Tankers (STNG) upgraded to Overweight from Neutral at JPMorgan with analyst Noah Parquette saying he's seen a considerable increase in interest from investors in the IMO 2020 product tanker story in recent weeks. 4. KB Home (KBH) and Taylor Morrison (TMHC) were upgraded to Outperform from Sector Perform at RBC Capital. 5. MYR Group (MYRG) upgraded to Buy from Hold at Stifel with analyst Noelle Dilts saying she sees "compelling dynamics" in the electric transmission and distribution market as utilities move investment toward power delivery in order to address reliability concerns, the need for grid hardening, and aging infrastructure. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/18
BARD
08/03/18
DOWNGRADE
BARD
Neutral
MYR Group downgraded to Neutral from Outperform at Baird
05/16/19
STFL
05/16/19
UPGRADE
Target $39
STFL
Buy
MYR Group upgraded to Buy from Hold at Stifel
Stifel analyst Noelle Dilts upgraded MYR Group to Buy from Hold and raised her price target for the shares to $39 from $32. The analyst sees "compelling dynamics" in the electric transmission and distribution market as utilities move investment toward power delivery in order to address reliability concerns, the need for grid hardening, and aging infrastructure. Further, she sees the 17% pullback in MYR shares post the company's Q1 results on May 2 as providing a good entry point. The outlook for MYR "remains strong," Dilts tells investors in a research note.
NVEE NV5 Global
$76.51

-0.35 (-0.46%)

03/08/19
ROTH
03/08/19
NO CHANGE
Target $90
ROTH
Buy
NV5 Global price target lowered to $90 from $97 at Roth Capital
Roth Capital analyst Jeff Martin maintained a Buy rating on NV5 Global but lowered his price target to $90 from $97 following the company's in line Q4 results. In a research note to investors, Martin says his investment thesis on NV5 centers around continued execution on strong organic growth, coupled with accretive acquisitions that expand geographic reach and service capability. He believes management's disciplined approach to M&A commands a premium valuation to peers and feels that fundamentals of the business are sound and that the material weakness is not a market-driving event.
03/08/19
MAXM
03/08/19
NO CHANGE
Target $93
MAXM
Buy
NV5 Global price target lowered to $93 from $110 at Maxim
Maxim analyst Tate Sullivan lowered his price target on NV5 Global after its Q1 earnings miss and its disclosure of accounting issues. The analyst is concerned with the company's slower conversion of backlog to revenue but keeps his Buy rating over the longer term. Sullivan attributes his positive stance to NV5 Global's regional infrastructure acquisition and integration strategy remaining intact, its rising free cash flows, and its low debt-to-EBITDA ratio.
05/09/19
ROTH
05/09/19
NO CHANGE
Target $96
ROTH
Buy
NV5 Global price target raised to $96 from $90 at Roth Capital
Roth Capital analyst Jeff Martin raised his price target for NV5 Global to $96 from $90, citing continued execution on "strong" organic growth driven by cross selling discipline, coupled with accretive acquisitions that expand geographic reach and service capability. The analyst believes management's disciplined approach to M&A commands a premium valuation to peers. He reiterates a Buy rating on the shares.
11/13/18
BOFA
11/13/18
INITIATION
Target $95
BOFA
Neutral
NV5 Global initiated with a Neutral at BofA/Merrill
BofA/Merrill analyst Anna Kaminskaya initiated NV5 Global with a Neutral and $95 price target. The analyst views NV5 as a unique E&C growth story with a successful M&A roll-up strategy over the past decade that is reflected in its premium multiple.
SGBX SG Blocks
$0.80

-0.05 (-5.88%)

TTEK Tetra Tech
$72.67

0.39 (0.54%)

05/06/19
ROTH
05/06/19
NO CHANGE
Target $75
ROTH
Buy
Tetra Tech price target raised to $75 from $66 at Roth Capital
Roth Capital analyst Gerry Sweeney raised his price target for Tetra Tech to $75 from $66 following quarterly results. The analyst notes that CIG margins were below target, but adds that these should improve substantially in the second half of 2019 driven by booked activity and run down of very low margin work in Canadian oil. State and Local could be the driver of upside versus guidance in the second half of the year, he contends. Sweeney reiterates a Buy rating on the shares.
04/09/19
SIDC
04/09/19
INITIATION
Target $79
SIDC
Buy
Tetra Tech re-initiated with a Buy at Sidoti
Sidoti re-initiated Tetra Tech with a Buy rating and $79 price target.
01/29/19
ROTH
01/29/19
NO CHANGE
Target $66
ROTH
Buy
Tetra Tech price target lowered to $66 from $73 at Roth Capital
Roth Capital analyst Gerry Sweeney lowered his price target for Tetra Tech to $66 from $73 ahead of quarterly results driven by a lower multiple due to overall increased risk. The analyst anticipates continued broad-based strength across the company's customer segments in the quarter, supported by record backlog. Near-term volatility in oil prices may dampen mid stream spending near-term, which could modestly trim margin expectations in 2H19, he contents. Sweeney reiterates a Buy rating on the shares.
01/29/19
ROTH
01/29/19
NO CHANGE
Target $66
ROTH
Buy
Tetra Tech price target lowered to $66 from $73 at Roth Capital
Roth Capital analyst Gerry Sweeney lowered his price target for Tetra Tech to $66 from $73 ahead of quarterly results driven by a lower multiple due to overall increased risk. The analyst anticipates continued broad-based strength across the company's customer segments in the quarter, supported by record backlog. Near-term volatility in oil prices may dampen mid stream spending near-term, which could modestly trim margin expectations in 2H19, he contents. Sweeney reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

SRPT

Sarepta

$127.90

-2.01 (-1.55%)

, PFE

Pfizer

$43.59

-0.09 (-0.21%)

11:11
06/24/19
06/24
11:11
06/24/19
11:11
On The Fly
Before the Move: Watch Sarepta ahead of Pfizer's DMD gene therapy data »

Ahead of the Parent…

SRPT

Sarepta

$127.90

-2.01 (-1.55%)

PFE

Pfizer

$43.59

-0.09 (-0.21%)

SLDB

Solid Biosciences

$4.91

-0.07 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 19

    Aug

  • 28

    Aug

  • 16

    Sep

GLW

Corning

$33.15

-0.1 (-0.30%)

11:08
06/24/19
06/24
11:08
06/24/19
11:08
Recommendations
Corning analyst commentary  »

Drop in LCD TV panel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$81.18

1.87 (2.36%)

11:05
06/24/19
06/24
11:05
06/24/19
11:05
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$45.86

-3.5 (-7.09%)

, CELG

Celgene

$94.16

-4.76 (-4.81%)

10:59
06/24/19
06/24
10:59
06/24/19
10:59
Periodicals
Bristol-Myers' merger headaches could be 'contagious,' STAT News says »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$45.86

-3.5 (-7.09%)

CELG

Celgene

$94.16

-4.76 (-4.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

LN

Line Corp.

$28.08

-0.17 (-0.60%)

10:54
06/24/19
06/24
10:54
06/24/19
10:54
Upgrade
Line Corp. rating change  »

Line Corp. now fairly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FXI

iShares China Large-Cap ETF

$42.65

0.15 (0.35%)

10:50
06/24/19
06/24
10:50
06/24/19
10:50
Options
Heavy call volume in China Largecap ETF adjusts existing position »

Heavy call volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAVM

PAVmed

$1.24

0.015 (1.22%)

10:49
06/24/19
06/24
10:49
06/24/19
10:49
Hot Stocks
PAVmed announces FDA 510(k) clearance for EsoCheck »

PAVmed announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LN

Line Corp.

$28.08

-0.17 (-0.60%)

10:46
06/24/19
06/24
10:46
06/24/19
10:46
Upgrade
Line Corp. rating change at Goldman Sachs »

Line Corp. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBX

Dropbox

$25.29

0.3 (1.20%)

10:45
06/24/19
06/24
10:45
06/24/19
10:45
Options
Dropbox call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
06/24/19
06/24
10:45
06/24/19
10:45
General news
U.S. Dallas Fed manufacturing index dropped another 6.8 points to -12.1 in June »

U.S. Dallas Fed…

AMZN

Amazon.com

$1,906.00

-4.42 (-0.23%)

, ULTA

Ulta Beauty

$354.70

-1.07 (-0.30%)

10:41
06/24/19
06/24
10:41
06/24/19
10:41
Hot Stocks
Amazon Business launches Amazon Professional Beauty Store »

Amazon (AMZN) has…

AMZN

Amazon.com

$1,906.00

-4.42 (-0.23%)

ULTA

Ulta Beauty

$354.70

-1.07 (-0.30%)

SBH

Sally Beauty

$14.65

-0.14 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 10

    Jul

  • 29

    Aug

AEGN

Aegion

$16.86

0.17 (1.02%)

10:38
06/24/19
06/24
10:38
06/24/19
10:38
Hot Stocks
Aegion appoints John Heggemann Chief Accounting Officer »

Aegion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:37
06/24/19
06/24
10:37
06/24/19
10:37
General news
Dallas Fed Mfg Survey General Activity Index data reported »

June Dallas Fed Mfg…

NOW

ServiceNow

$282.05

-3.7 (-1.29%)

10:35
06/24/19
06/24
10:35
06/24/19
10:35
Options
ServiceNow put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$40.80

-0.26 (-0.63%)

10:33
06/24/19
06/24
10:33
06/24/19
10:33
Conference/Events
Biohaven Pharmaceutical management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LVS

Las Vegas Sands

$59.26

0.08 (0.14%)

10:25
06/24/19
06/24
10:25
06/24/19
10:25
Options
Las Vegas Sands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$123.84

-0.41 (-0.33%)

, HMSY

HMS Holdings

$31.56

-0.3 (-0.94%)

10:24
06/24/19
06/24
10:24
06/24/19
10:24
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

SPLK

Splunk

$123.84

-0.41 (-0.33%)

HMSY

HMS Holdings

$31.56

-0.3 (-0.94%)

CNCE

Concert Pharmaceuticals

$11.60

0.7 (6.42%)

AWI

Armstrong World

$97.57

-0.25 (-0.26%)

RMTI

Rockwell Medical

$3.03

0.04 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 09

    Jul

  • 11

    Jul

SON

Sonoco

$64.65

-0.75 (-1.15%)

, OXY

Occidental Petroleum

$50.26

-0.36 (-0.71%)

10:24
06/24/19
06/24
10:24
06/24/19
10:24
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

SON

Sonoco

$64.65

-0.75 (-1.15%)

OXY

Occidental Petroleum

$50.26

-0.36 (-0.71%)

IP

International Paper

$42.60

-1.02 (-2.34%)

SHOP

Shopify

$314.70

-11.98 (-3.67%)

SPOT

Spotify

$149.34

1.17 (0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 18

    Jul

  • 27

    Aug

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 17

    Oct

UTX

United Technologies

$129.86

1.08 (0.84%)

, DE

Deere

$167.61

3.32 (2.02%)

10:24
06/24/19
06/24
10:24
06/24/19
10:24
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

UTX

United Technologies

$129.86

1.08 (0.84%)

DE

Deere

$167.61

3.32 (2.02%)

AGCO

Agco

$76.46

1.75 (2.34%)

RCII

Rent-A-Center

$24.45

0.27 (1.12%)

TWNK

Hostess Brands

$14.14

0.25 (1.80%)

DNKN

Dunkin' Brands

$80.65

1.11 (1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 17

    Jul

HD

Home Depot

$208.70

-0.75 (-0.36%)

10:23
06/24/19
06/24
10:23
06/24/19
10:23
Hot Stocks
Breaking Hot Stocks news story on Home Depot »

Home Depot CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 20

    Aug

APEN

Apollo Endosurgery

$3.84

(0.00%)

10:23
06/24/19
06/24
10:23
06/24/19
10:23
Recommendations
Apollo Endosurgery analyst commentary at Piper Jaffray »

Piper says Apollo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$207.99

-1.46 (-0.70%)

, LOW

Lowe's

$100.16

-0.66 (-0.65%)

10:18
06/24/19
06/24
10:18
06/24/19
10:18
Hot Stocks
Home Depot CEO says lumber price weakness continues »

Home Depot (HD) CEO Craig…

HD

Home Depot

$207.99

-1.46 (-0.70%)

LOW

Lowe's

$100.16

-0.66 (-0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 20

    Aug

  • 21

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
06/24/19
06/24
10:17
06/24/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
06/24/19
06/24
10:16
06/24/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$162.71

-2.6 (-1.57%)

10:15
06/24/19
06/24
10:15
06/24/19
10:15
Options
Fedex put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.